Menu

CRISPR Pioneers Honored

Influential researchers receive the 2015 Breakthrough Prizes in Life Sciences.

Nov 18, 2014
Molly Sharlach

Emmanuelle Charpentier, Jennifer Doudna, and Victor Ambros, recipients of 2015 Breakthrough Prizes in Life Sciences.BREAKTHROUGH PRIZE

The 2015 Breakthrough Prizes in Life Sciences recognized six scientists for their achievements in gene editing, gene regulation, and Parkinson’s therapy. The $3 million prizes are sponsored by a group of tech billionaires, including Russian entrepreneur Yuri Milner, Mark Zuckerberg of Facebook, and Sergey Brin of Google. The prizes were awarded earlier this month (November 9) at a televised ceremony in Mountain View, California.

Emmanuelle Charpentier of the Helmholtz Center for Infection Research in Germany and Umeå University in Sweden, and Jennifer Doudna of the University of California, Berkeley, were honored for discovering the details of CRISPR, a bacterial antiviral system that has been widely adapted for genetic engineering.

Doudna was “thrilled and shocked and very excited” to learn of the award, she told The Guardian. “We published our work in 2012 and none of us could have predicted how transformative it has been.” The CRISPR-Cas9 system has already proven to be a powerful research tool, and also shows promise as a method for gene therapy to treat cystic fibrosis and blood disorders.

Other award recipients included neurosurgeon Alim Louis Benabid of Joseph Fourier University in France, for his work on deep-brain stimulation as a therapy for Parkinson’s disease, and Victor Ambros of the University of Massachusetts Medical School and Gary Ruvkun of Harvard Medical School for their research on gene regulation by microRNAs.

C. David Allis of The Rockefeller University in New York was recognized for his work on epigenetics—specifically, covalent modifications of histone proteins with broad effects on gene regulation and disease.

“When you decide to pursue a very basic problem in life sciences like gene regulation, you never expect to receive a prize as remarkable as the Breakthrough Prize. It shows how wonderful a career in science is,” Allis told The Guardian

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.